The results, published May 5 in Nature Genetics, offer a new way to understand the molecular roots of cancer — an especially ...
Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the ...
Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...
Immunotherapy is a revolutionary cancer treatment strategy that leverages the body’s immune system to fight cancer. While immune checkpoint inhibitors significantly improve the therapeutic outcomes in ...
Researchers at the Johns Hopkins Kimmel Cancer Center and the Telomere Clinic at Johns Hopkins have identified a genetic ...
When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...
Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...
After a cancer diagnosis, patients often have many questions, not only about their treatment but also about what the ...
The BRAF mutation affects a small percentage of non-small cell lung cancer (NSCLC) cases, making the cancer more difficult to treat. In recent years, advances in treatment have helped to improve ...
A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results